Active Infection & Immunity Lungs & Breathing

Understanding the adaptability of Aspergillus fumigatus

In plain English

AI plain-English summary

The fungus *Aspergillus fumigatus* kills more people than any other fungal pathogen, and it is rapidly evolving resistance to the only drugs that stop it. This matters because serious fungal infections are a growing global threat, and antifungal medications are essential for treating them. Resistance is emerging faster than new drugs can be developed. The researcher has already identified a key driver of this adaptability—mutator phenotypes that speed up genetic change—but does not yet know how they interact with other mechanisms, such as horizontal gene transfer and sexual reproduction, to help the fungus survive in complex environments like a patient’s lungs. If this research succeeds, it will map the genetic and environmental factors that allow *A. fumigatus* to adapt so quickly. That knowledge could guide the design of smarter treatment strategies—for example, identifying when combination therapies might slow resistance, or pinpointing which environments in hospitals or farms are most likely to breed resistant strains. This is fundamental science: it will not produce a new drug tomorrow, but understanding the fungus’s evolutionary playbook is a necessary first step toward outmanoeuvring it.

View original technical description
Serious fungal infections pose a unique challenge to human health, causing severe and life-threatening disease. Antifungal medications are essential for the treatment of fungal disease, but resistance is rapidly emerging across the globe. This is particularly concerning for Aspergillus fumigatus (Af) which is responsible for more deaths than any other fungal pathogen. Understanding the factors driving the remarkable adaptability of Af is essential for developing effective strategies to mitigate the risk of resistance emergence. Adaptability in Af is driven by multiple mechanisms including mutation, horizontal gene transfer and sexual reproduction. Here, I will investigate the contribution of each to understand how Af adapts to complex and changing environments by developing and implementing interdisciplinary tools. I will determine the interplay between mutator phenotypes, which I have recently identified, and stress in generating genetic diversity. Next, I will develop a new framework to understand hyphal fusion and horizontal genetic transfer in Af. Finally, I will map the polygenic and epistatic architecture of Af, explaining how Af adapts to complex multi-stress heterogenous environments. By unravelling the complex interplay of genetic and environmental factors that shape Af evolution, this research will provide critical information needed to combat the growing threat of drug-resistant fungal infections.

View the original record at the funder ↗

Researchers

Michael Bottery (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

A One Health approach to combatting AMR in the human pathogen Aspergillus fumigatus.
Molecular dynamics of resistance and persistence of Aspergillus fumigatus
Deciphering the Epigenetic Gene Regulatory Landscape in the Major Mould Pathogen of Human Lungs
Improving detection and diagnosis of antimicrobial resistance in Aspergillus fumigatus
Explore the mutational trajectories shaping fungal adaptation

Original classification

Career Development Award

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.